Did you know that the FDA was involved in a PRP study? This is great news! While PRP has proven to be an extremely beneficial pain reducer for a number of orthopedic problems, it is still considered “experimental.” Just like many medications that are currently used “off-label,” such as: Botox for wrinkles, Coumadin for heart disease, or Singulair for COPD, PRP is also used “off-label” when injected for pain relief. Unlike the above-mentioned pharmaceuticals, however, PRP comes from your own cells to help your body cope with pain and orthopedic conditions naturally.
Therefore, it is very exciting that the FDA was involved in Dr. Smith’s clinical trial comparing PRP to saline placebo injections. The study, Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial, concludes that patients who received PRP injections had quantifiable pain relief and functional improvement over the patients who received saline placebo injections. After a year, patients who received PRP injections had pain scores that improved by 78% vs. only a 7% improvement in the placebo group.
If you are interested in PRP injections and would like more information about how this treatment might help you, call Gitelis Orthopedics!